• locale

  Germany

• market

  STOCKS

• industry

  Drug Manufacturers - Specialty & Generic

• website

  www.synbiotic.com

• ipo date

  Jan 07, 2021

SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.

*Estimate based on analyst consensus